| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Illumina, Inc. (ILMN) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. ILMN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.50M | $565.67M | - | |
| Dir | 2.83M | $457.18M | -669,596 | |
| CEO | 82.1K | $13.26M | - | |
| VP | 41.9K | $6.77M | - | |
| VP | 33.0K | $5.34M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 20, 2020 | Flatley Jay T47 | Director | Sell | 4,000 | $321.72 | $1,286,860.00 | -1.0% | |
| Oct 12, 2020 | Tousi Susan H81 | SVP Product Development | Sell | 200 | $350.00 | $70,000.00 | -0.4% | |
| Oct 7, 2020 | Tousi Susan H81 | SVP Product Development | Sell | 100 | $325.00 | $32,500.00 | -0.2% | |
| Oct 7, 2020 | Flatley Jay T47 | Director | Sell | 1,000 | $324.01 | $324,010.00 | -0.5% | |
| Oct 6, 2020 | Flatley Jay T47 | Director | Sell | 3,000 | $317.79 | $953,370.00 | -1.4% | |
| Oct 1, 2020 | Desouza Francis A | President And CEO | Sell | 3,000 | $308.78 | $926,330.58 | -0.6% | |
| Oct 1, 2020 | Dadswell Charles82 | SVP &General Counsel | Sell | 121 | $312.82 | $37,851.22 | -1.9% | |
| Sep 15, 2020 | Flatley Jay T47 | Director | Sell | 4,000 | $355.22 | $1,420,880.00 | -1.9% | |
| Sep 9, 2020 | Tousi Susan H81 | SVP Product Development | Sell | 300 | $345.33 | $103,600.00 | -0.3% | |
| Sep 1, 2020 | Van Oene Mark79 | SVP Chief Commercial Officer | Sell | 625 | $355.13 | $221,953.16 | -1.7% |